GeneExpression Systems of USA and University of Cambridge of UK
Appasani Research Conferences (ARCEI.ORG)
Jointly Presents

11th International
MicroRNAs & NonCoding RNAs & Genome Editing Europe 2016 Meeting
On
MicroRNAs/NcRNAs: Biology to Development and Disease & CRISPRs Interference

November 1 - 2, 2016

Venue: Peterhouse, University of Cambridge, Cambridge, UK

A Unique Theme Conference & Exhibition in the MicroRNomics & Genome Editing

Meeting Place:

The Venue Peterhouse (middle) is the oldest College of the University of Cambridge, founded in 1284 and an institution dedicated to education and research. Throughout its history, Petreans have been at the heart of the political, social and religious controversies that have shaped today’s society. Some of the influential Petreans include: Henry Cavendish, Lord Kelvin, Sir Frank Whittle and Christopher Cockerill, and Nobel Laureates – Sir John Kendrew, Sir Aaron Klug, Archer Martin and Max Perutz , who gave a twentieth century lead in the field of Molecular Biology. Since many centuries it remained as a hub for innovation and successive generations of the brightest young people around the world.

Why do you wait to join for an intellectual gathering in the ‘microRNomics’ arenas at the prestigious college Peterhouse in the Premier University campus!

SCOPE OF THE MEETINGS: 

The purpose and scope of this two-day intensive unique single track and intellectual European Symposia - 2016 (on November 1 – 2, 2016) is to provide a forum for the discussion of the current state of the art of rapidly evolving MicroRNAs/ Noncoding RNAs, Genome Engineering/Editing and their applications in gene expression, stem cells and various diseases.

1. MicroRNAs/Noncoding RNAs& Genome Editing Europe - 2016: This is our 11th international theme conference continuously held in this college in the first week of November in Cambridge, England. Professors Julie Ahringer and Eric Miska of the University of Cambridge inaugurated our first meeting in November 2006. Since then, Nobel Laureates Drs. Tim Hunt, John Walker; and pioneers in MicroRNAs fields including: Drs. David Baulcombe (UK), Carlo Croce (USA), Gunter Meister (Germany), Mike Gait (UK), Rene Ketting (Germany) and many more have given keynote speeches. MicroRNAs/Noncoding RNAs are the “biology’s Big Bang” and we are igniting the spirit of both  Micro/LNcRNomics in order to understand the biology of these molecules and their pivotal role(s) in diseases in order to develop innovative products based on this technology platform.

Additionally, Synthetic Biology and Genome Engineering using genome editing tools such as nucleases is also evolving at a rapid speed. Therefore, this meeting will also focus on the study of genome editing using ZFNs, TALENs and CRISPR/Cas systems in depth in order to develop novel reagent/assay/tool and drug targets.In this international meeting, prominent researchers (Developmental biologists, cell biologists, geneticists, molecular biologists, computational biologists, neurobiologists, clinicians, chemists, bioengineers, synthetic biologists and physicists)  from both academia and industry will gather and discuss the applications in form of keynote lectures, invited talks, short oral, and poster presentations.
These meetings are open for graduate students, postdoctoral fellows and professors from academia and research scientists and executives from bio-pharma industry to gain insights in the emerging frontiers in biotechnology.

Venue: The Venue Peterhouse is the oldest College of the University of Cambridge, located close to the banks of Cam River. This college has produced science giants such as: Henry Cavendish, Lord Kelvin, Sir Frank Whittle and Christopher Cockerill, and Nobel Laureates – Sir John Kendrew, Sir Aaron Klug, Archer Martin and Max Perutz. Participate in this meeting and become proud attending member of this prestigious college in the world.

Note: All the members (except keynote speakers and others who arranged with organizer) who participate in this symposium have to register for the meeting by paying the appropriate registration fee. All the registered participants has the leverage to attend any parallel session they are interested.

Click Here for Agenda

Tuesday, November 1, 2016
8:00A.M: Registration Open 
8.45 AM – 6.30 PM Scientific Sessions 

Wednesday, November 2, 2016
8:00A.M: Registration Open 
9.00 AM – 6.00 PM Scientific Sessions

Scientific Organizer:

Krishnarao Appasani, PhD., MBA, FRSB Founder & CEO GeneExpression Systems, Inc Waltham, MA USA

Scientific Committee:

	Andrew Bassett, PhD.               Head of Genome Engineering Oxford University of Oxford& Wellcome Trust Sanger Institute Hinxton, Cambridge, United Kingdom

Key Sessions:

Keynote Speakers:

	Anton J. Enright, PhD. Group Leader EMBL - European Bioinformatics Institute Wellcome Trust Genome Campus Hinxton, Cambridgeshire, UK Title: New methods for profiling and de novo prediction of microRNAs from NGS data.
	Industry Keynote TBA Exiqon A/S Vedbaek, Denmark Title: TBA

Other Speakers:

Micro/NonCoding RNAs & Editing
	Michela Garofalo, PhD.                                            Group Leader in Cancer Research UK Manchester Inst University of Manchester Manchester, United Kingdom Title: MicroRNA regulation and dysregulation in non-small cell lung cancer		EylonYavin, PhD. Senior Lecturer in Pharmacy The Hebrew University of Jerusalem Jerusalem, Israel Title: Peptide Nucleic Acids (PNAs) as diagnostic tools for RNA detection in cancer
	Victor Dillard Chief Operating officer Desktop Genetics Ltd. London, United Kingdom Title: Bioinformatic tools to design genome editing experiments using CRISPR/Cas9 system		Irene MenciaCastano, PhD. Postdoctoral Fellow in Bioengineering & Regenerative Medicine Royal College of Surgeons in Ireland Dublin, Ireland Title: Collagen-based scaffolds for microRNA delivery to enhance tissue regeneration
	Damien Hermand, PhD. Assistant Professor of Biology University of Namur Namur, Belgium Title: Stepwise chromatin remodeling by two lincRNAs underlies cell fate in fission yeast		Bernadette Baker, PhD. Research Associate University of Manchester Manchester, United Kingdom Title: Folate deficiency alters expression of placental microRNAs in vivo and in vitro
	Wendy J.M. Huang, PhD. Irvington Institute Fellow New York University School of Medicine New York, NY, USA Title: Noncoding RNAs in T-cell-mediated physiological and pathological processes		Haiming Cao,PhD.                                        Investigator NHLBI, National Institutes of Health Bethesda, MD, USA Title: Regulation of systemic energy metabolism by long noncoding RNAs
	Johan Jakobsson PhD. Assistant Professor of Neuroscience Lund Stem Cell Center-Lund University Lund, Sweden Title: A link between autophagy and miRNA-biogenesis - implications for neurodegeneration		Lei Sun, PhD. Assistant Professor, Cardiovascular & Metabolic Disorders Duke-NUS Graduate Medical School Singapore Title: De novo reconstruction of adipose tissue transcriptomes reveals novel long Noncoding RNAs that regulate brown adipocyte development
	Caifu Chen, Ph.D.                                         Sr. Vice President of R&D Integrated DNA Technologies Redwood City, CA, USA Title: New roles of miR-34 in cancer and stem cell pluripotency		Geraldo A. Passos, PhD. Professor of Genetics & Molecular Biology University of São Paulo-RibeirãoPreto Medical School RibeirãoPreto, SP, Brasil Title: siRNA and CRISPR-Cas9-mediated knockdown provides evidence that autoimmune regulator gene controls cell adhesion
	Gary P. Brennan, PhD. Research Fellow in Physiology & Medical Physics Royal College of Surgeons in Ireland Dublin, Ireland Title: Dual and Opposing roles of microRNA-124 in epileptogenesis are mediated via NRSF/REST and inflammatory pathways		Alfonso H. Magadán, PhD. Research Scientist Chr. Hansen A/S Hoersholm, Denmark Title: Genome Editing to generate industrial  strains
	Meritxell Pons Espinal, PhD. Postdoctoral Fellow in Neuroscience Italian Institute of Technology Genova, Italy  Title: Adult Neural Stem Cell-fate commitment into neurons or astrocytes is determined by Dicer-dependent miRNAs		Stephen G. Maher, PhD. Senior Lecturer in Biomedical Science University of Hull, Hull, UK& Adjunct Associate Professor, Trinity College, Ireland Title: MicroRNA mediated regulation of sensitivity to chemoradiotherapy in oesophageal adenocarcinoma
	Yoko Matsuno, MD. PhD. Researcher in Clinical Preventive Medicine Niigata University-Graduate School of Medicine Niigata-shi, Niigata, Japan Title: Localization of Xist/XIST RNAs and their interaction with chromatin		Stefan J. Erkeland, PhD. Group Leader/Assistant Professorin Hematology Erasmus University Medical Center Rotterdam, The Netherlands Title: Regulation of miR-139-3p and miR-199a-3p in leukemic transformation
	Andrea Caporali, PhD.  Chancellor's FellowatCardiovascular Science Ctr. University of Edinburgh Edinburgh, Scotland-UK Title: microRNAscontrol therapeutic angiogenesis		Fabio Martelli, PhD. Director of Molecular Cardiology Laboratory IRCCS-Policlinico San Donato San Donato Milanese, Milan, Italy Title: Noncoding RNAs in ischemic heart failur
	BoyeSchnack Nielsen, PhD. Business and Research Manager, Molecular Histology Bioneer A/S Hørsholm,Denmark Title: Cancer associated miR-21 and assessment by image analysis		Marie-Laure Baudet, PhD. Group Leader in Center for Integrative Biology University of Trento Povo, Trento, Italy Title: microRNAs: subcellular action in neurons during brain wiring
	Carlos P. Fitzsimons, PhD. Assistant Professor of Neuroscience University of Amsterdam Amsterdam, The Netherlands Title: Two is better than one. Cooperative gene regulation by microRNAs in neural stem cells		Peter Leedman, MBBS, PhD. Professor and Director Harry Perkins Inst. of Medical Research University of Western Australia, Nedlands, WA, Australia Title: microRNA candidates for replacement therapy
	Leon J. de Windt, PhD. Professor of Molecular Cardiovascular Biology Maastricht University Maastricht, The Netherlands Title: MicroRNA therapeutics in cardiovascular disease		Dr. Rodrigo M. Maza Senior Scientist in Molecular Neuroprotection Group Hospital Nacional de Parapléjicos Toledo, Spain Title: MicroRNA dysregulation in the spinal cord following traumatic injury
	Laurence Amar, PhD. Researcher in Molecular Neuroendocrinology University of Paris-Sud 11 Orsay, France Title: microRNA populations of hypothalamic arcuate nucleus and median eminence in rat. Lack of significant influence of perinatal or adult diet/metabolism at early postnatal development stages or in adults		Emmanuelle Vire, PhD. Investigator Scientist UCL Neurology Institute, London, UK Title: Identification of non-coding RNAs involved in neurodegeneration
	Alain Sewer, PhD. Scientist, Disease Modeling & Simulation R & D Philip Morris International Neuchatel, Switzerland Title: MicroRNA expression from a 90-day rat inhalation study indicate that exposure to THS 2.2 aerosol causes reduced effects on lung tissue compared with cigarette smoke		Masato Ohtsuka, PhD. Associate Professorof Molecular Life Science Tokai University School of Medicine Isehara, Kanagawa, Japan Title: Generation of knockdown mice using PITT and Isi-CRISPR
	Tatiana Ruksha, MD, PhD. Chair of Pathophysiology Department Krasnoyarsk State Medical University Krasnoyarsk, Russian Federation Title: MicroRNA expression pattern alterations and functional study of miR-4286 inhibition in melanoma		Abdoulaye Baniré Diallo PhD. Professor of Computer Science University of Quebec at Montreal Montreal, Quebec, Canada Title: Machine learning in small RNA and regulatory elements

* *Presenting Speaker names, title and times are subject to change.
Host organization, organizer, or scientific committee does not take any kind of responsibility.

Exhibitors are welcome to reserve their booth space early!

Please contact if you are interested in speaking in the scientific or Technology workshops of this meeting.

GeneExpression Systems, Inc.
P.O. Box 540170
Waltham, MA 02454 USA
Tel: (781) 891-8181
Fax: (781)730-0700 or (781) 891-8234

E-mail: Genexpsys@expressgenes.com
www.expressgenes.com

Note: Speakers Names, Titles and venue subjected to change beyond our control for which the company is not responsible.